Every result, read before it lands. Judged after.
Sign in
NIFTY 50 22,776.10 +0.98% NIFTY BANK 55,128.40 +0.76% NIFTY IT 28,136.05 -0.59% NIFTY MIDCAP 100 59,761.20 +1.08% NIFTY SMALLCAP 100 19,448.70 +1.56% NIFTY AUTO 25,541.95 +0.47% NIFTY PHARMA 26,549.60 +1.66% NIFTY FMCG 45,205.35 +1.40%
Closed Close 6 Oct

Indo Us Biotech Limited · INDOUS

Every Indo Us Biotech Limited result whose ten-session window has closed, judged against the last read made before it. Open a result for the full account: the read, the sessions after, the reported figures, and every morning's read that led up to it. The company's own page →

8results judged
0read right
0read wrong
0flat / no call
8unread
38%beat the market
+0.1%avg vs market, 10d
4.8%avg move, T+1

How the reads on it fared

ReadJudgedRightWrongFlatHit rateAvg vs mkt
unread 8 0 0 0 — +0.1%

A company that is often read strong and often proves it is one the model understands; one that is read strong and keeps lagging is where the model is wrong about a name, and this table is where that shows first.

Reading the rows

T+1
the share's move on the first session after the result, from the close before it
T+10
the move over ten sessions, same base
vs market
T+10 less NIFTY 50's move over the same ten sessions — the number every read is judged on
Run-up
the share's move in the thirty sessions before the result
Result
reported profit growth against the company's own last four quarters: good, in line, bad

Each result

8 judged · newest first · open one
ResultReadOutcomeT+1T+10vs marketRun-upResultWhy
12 Aug Q1FY27 — unread +0.7% +0.4% +1.8% -9% no figures
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • Went into the result within 5% of its 52-week low.
  • 1 more
 ›
29 May Q4FY26 — unread -1.9% -9.8% -11.1% -9% no figures
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • Went into the result within 5% of its 52-week low.
  • 1 more
 ›
21 Jan Q3FY26 — unread +5.7% +13.3% +11.2% -13% no figures
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • Went into the result within 5% of its 52-week low.
  • 2 more
 ›
14 Nov Q2FY26 — unread -4.9% -3.5% -4.5% -2% no figures
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • No read was made before this result; recorded for the base rate.
 ›
12 Aug Q1FY26 — unread -6.8% -11.7% -11.4% +10% no figures
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • No read was made before this result; recorded for the base rate.
 ›
26 May Q4FY25 — unread +9.9% +12.2% +11.8% -4% no figures
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • Volume ran 1.6x its prior month in the fortnight before.
  • 1 more
 ›
11 Feb Q3FY25 — unread +0.2% -9.2% -6.9% -30% no figures
  • Fell 30% in the 30 sessions before the result — expectations were already low.
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • 1 more
 ›
14 Nov Q2FY25 — unread +8.4% +12.4% +10.0% -25% no figures
  • Fell 25% in the 30 sessions before the result — expectations were already low.
  • No reported figures on file for this quarter, so the result itself could not be judged.
  • 3 more
 ›